13-28049450-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004119.3(FLT3):​c.970G>A​(p.Asp324Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0212 in 1,613,454 control chromosomes in the GnomAD database, including 423 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. D324D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.016 ( 19 hom., cov: 33)
Exomes 𝑓: 0.022 ( 404 hom. )

Consequence

FLT3
NM_004119.3 missense

Scores

2
16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: -0.0930

Publications

39 publications found
Variant links:
Genes affected
FLT3 (HGNC:3765): (fms related receptor tyrosine kinase 3) This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. This receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia. [provided by RefSeq, Jan 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031169355).
BP6
Variant 13-28049450-C-T is Benign according to our data. Variant chr13-28049450-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 134451.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0158 (2402/151888) while in subpopulation NFE AF = 0.0243 (1651/67916). AF 95% confidence interval is 0.0233. There are 19 homozygotes in GnomAd4. There are 1103 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 2402 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLT3NM_004119.3 linkc.970G>A p.Asp324Asn missense_variant Exon 8 of 24 ENST00000241453.12 NP_004110.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLT3ENST00000241453.12 linkc.970G>A p.Asp324Asn missense_variant Exon 8 of 24 1 NM_004119.3 ENSP00000241453.7
FLT3ENST00000380987.2 linkn.970G>A non_coding_transcript_exon_variant Exon 8 of 25 1 ENSP00000370374.2

Frequencies

GnomAD3 genomes
AF:
0.0158
AC:
2401
AN:
151768
Hom.:
19
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00410
Gnomad AMI
AF:
0.00549
Gnomad AMR
AF:
0.0136
Gnomad ASJ
AF:
0.0407
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00793
Gnomad FIN
AF:
0.0136
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0243
Gnomad OTH
AF:
0.0192
GnomAD2 exomes
AF:
0.0172
AC:
4328
AN:
251354
AF XY:
0.0177
show subpopulations
Gnomad AFR exome
AF:
0.00357
Gnomad AMR exome
AF:
0.0107
Gnomad ASJ exome
AF:
0.0429
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0135
Gnomad NFE exome
AF:
0.0246
Gnomad OTH exome
AF:
0.0214
GnomAD4 exome
AF:
0.0218
AC:
31838
AN:
1461566
Hom.:
404
Cov.:
32
AF XY:
0.0215
AC XY:
15632
AN XY:
727096
show subpopulations
African (AFR)
AF:
0.00424
AC:
142
AN:
33478
American (AMR)
AF:
0.0109
AC:
486
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0410
AC:
1071
AN:
26128
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39690
South Asian (SAS)
AF:
0.00870
AC:
750
AN:
86230
European-Finnish (FIN)
AF:
0.0158
AC:
846
AN:
53390
Middle Eastern (MID)
AF:
0.0208
AC:
120
AN:
5768
European-Non Finnish (NFE)
AF:
0.0243
AC:
27018
AN:
1111772
Other (OTH)
AF:
0.0232
AC:
1401
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1529
3057
4586
6114
7643
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1014
2028
3042
4056
5070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0158
AC:
2402
AN:
151888
Hom.:
19
Cov.:
33
AF XY:
0.0149
AC XY:
1103
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.00408
AC:
169
AN:
41376
American (AMR)
AF:
0.0136
AC:
208
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.0407
AC:
141
AN:
3464
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5154
South Asian (SAS)
AF:
0.00793
AC:
38
AN:
4792
European-Finnish (FIN)
AF:
0.0136
AC:
144
AN:
10612
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0243
AC:
1651
AN:
67916
Other (OTH)
AF:
0.0190
AC:
40
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
126
252
378
504
630
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0215
Hom.:
119
Bravo
AF:
0.0153
TwinsUK
AF:
0.0232
AC:
86
ALSPAC
AF:
0.0215
AC:
83
ESP6500AA
AF:
0.00409
AC:
18
ESP6500EA
AF:
0.0235
AC:
202
ExAC
AF:
0.0165
AC:
2005
Asia WGS
AF:
0.00260
AC:
10
AN:
3478
EpiCase
AF:
0.0261
EpiControl
AF:
0.0242

ClinVar

Significance: Likely benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1Other:1
Jun 21, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

FLT3-related disorder Benign:1
May 26, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
13
DANN
Benign
0.91
DEOGEN2
Benign
0.39
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.081
N
LIST_S2
Benign
0.68
T
MetaRNN
Benign
0.0031
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.14
N
PhyloP100
-0.093
PrimateAI
Uncertain
0.50
T
PROVEAN
Uncertain
-3.3
D
REVEL
Benign
0.041
Sift
Benign
0.15
T
Sift4G
Benign
0.24
T
Polyphen
0.0050
B
Vest4
0.12
MPC
0.13
ClinPred
0.0084
T
GERP RS
0.90
Varity_R
0.20
gMVP
0.46
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35602083; hg19: chr13-28623587; COSMIC: COSV54048091; API